Understanding Prostate Cancer Care for Immigrant Men
This study, called iCCARE Project #4, is looking to understand how being an immigrant from Sub-Saharan Africa or the Caribbean affects prostate cancer care and survivorship for men. Researchers will conduct interviews to learn about the social, environmental, and behavioral factors that impact these men's experiences in the U.S. You may be able to join if you are a Black or African American man, 18 years or older, who identifies as a Caribbean or Sub-Saharan African immigrant, has a U.S. address, can read and write in English, and was diagnosed with prostate cancer within the last 10 years. The main goal is to understand the safety and any side effects participants might experience. The study aims to enroll 40 participants, but its current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 40 participants. It is not specified if it is randomized or blinded.
- What's involved
- You would participate in interviews, which can be done in person, over the phone, or via Zoom. The study will follow participants for an average of 1 year.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed through study completion, which is an average of 1 year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lorna McNeill, MPH,PHD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Safety and Adverse Events (AEs)Through study completion; an average of 1 year
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0